132P Health economic properties of palbociclib in breast cancer patients with high risk of relapse following neoadjuvant therapy: Results from the Penelope-B trial

Authors :: Matthias Schwenkglenks
Nicole McCarthy
Harry D. Bear
Andreas Makris
Nicole Burchardi
M. Toi
P. Salari
Michael Untch
M. Martin
F Marmé
T. Reimer
HS Rugo
JA Garcia-Saenz
S. Loibl
Catherine M. Kelly
K. Galactionova
M. Gnant
Karen A. Gelmon
S-B Kim
Hervé Bonnefoi
Source :: Annals of Oncology. 32:S416-S417
Publication Year :: 2021
Publisher :: Elsevier BV, 2021.

Subjects :: Oncology
medicine.medical_specialty
business.industry
medicine.medical_treatment
Hematology
Palbociclib
medicine.disease
Breast cancer
Internal medicine
medicine
Relapse risk
business
Neoadjuvant therapy

Tools